CORT
CORCEPT THERAPEUTICS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
CORCEPT THERAPEUTICS INC (CORT) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$490.49M; the largest are Renaissance Technologies, Izzy Englander, Ken Griffin. 4 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 2 added, 3 trimmed, 2 closed. 7 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders54 also report options
Congress trades7
Price$114.74vs quarter-end+31.96%
Sectors0
This quarter's moves
Top holderNew0
Added2
Trimmed / sold5
Renaissance TechnologiesCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $22.41M— of portfolio257,7002026 Q2
Value $5.53M— of portfolio63,6002026 Q2
Value $5.12M— of portfolio58,9002026 Q2
Value $1.35M— of portfolio15,5002026 Q2
Value $843.4K— of portfolio9,7002026 Q2
Value $521.7K— of portfolio6,0002026 Q2
Value $356.5K— of portfolio4,1002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $22.41M | — | — |
| Izzy EnglanderCALL | $5.53M | — | — |
| Ken GriffinPUT | $5.12M | — | — |
| Paul Tudor JonesPUT | $1.35M | — | — |
| Paul Tudor JonesCALL | $843.4K | — | — |
| Steven CohenPUT | $521.7K | — | — |
| Steven CohenCALL | $356.5K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.